全文获取类型
收费全文 | 84945篇 |
免费 | 6038篇 |
国内免费 | 332篇 |
专业分类
耳鼻咽喉 | 1083篇 |
儿科学 | 2011篇 |
妇产科学 | 1272篇 |
基础医学 | 10178篇 |
口腔科学 | 2046篇 |
临床医学 | 9451篇 |
内科学 | 17914篇 |
皮肤病学 | 1652篇 |
神经病学 | 7925篇 |
特种医学 | 2829篇 |
外科学 | 13594篇 |
综合类 | 1087篇 |
一般理论 | 94篇 |
预防医学 | 7066篇 |
眼科学 | 1620篇 |
药学 | 5618篇 |
2篇 | |
中国医学 | 82篇 |
肿瘤学 | 5791篇 |
出版年
2023年 | 341篇 |
2022年 | 526篇 |
2021年 | 1511篇 |
2020年 | 884篇 |
2019年 | 1517篇 |
2018年 | 1777篇 |
2017年 | 1349篇 |
2016年 | 1552篇 |
2015年 | 1739篇 |
2014年 | 2476篇 |
2013年 | 3552篇 |
2012年 | 5437篇 |
2011年 | 5861篇 |
2010年 | 3177篇 |
2009年 | 2952篇 |
2008年 | 5198篇 |
2007年 | 5376篇 |
2006年 | 5347篇 |
2005年 | 5379篇 |
2004年 | 5055篇 |
2003年 | 4809篇 |
2002年 | 4545篇 |
2001年 | 1404篇 |
2000年 | 1377篇 |
1999年 | 1369篇 |
1998年 | 1018篇 |
1997年 | 842篇 |
1996年 | 768篇 |
1995年 | 764篇 |
1994年 | 623篇 |
1993年 | 565篇 |
1992年 | 898篇 |
1991年 | 856篇 |
1990年 | 801篇 |
1989年 | 680篇 |
1988年 | 696篇 |
1987年 | 649篇 |
1986年 | 654篇 |
1985年 | 659篇 |
1984年 | 554篇 |
1983年 | 528篇 |
1982年 | 537篇 |
1981年 | 495篇 |
1980年 | 382篇 |
1979年 | 420篇 |
1978年 | 367篇 |
1977年 | 313篇 |
1976年 | 232篇 |
1974年 | 268篇 |
1973年 | 256篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
Auda A. Eltahla Fabio Luciani Peter A. White Andrew R. Lloyd Rowena A. Bull 《Viruses》2015,7(10):5206-5224
The hepatitis C virus (HCV) is a pandemic human pathogen posing a substantial health and economic burden in both developing and developed countries. Controlling the spread of HCV through behavioural prevention strategies has met with limited success and vaccine development remains slow. The development of antiviral therapeutic agents has also been challenging, primarily due to the lack of efficient cell culture and animal models for all HCV genotypes, as well as the large genetic diversity between HCV strains. On the other hand, the use of interferon-α-based treatments in combination with the guanosine analogue, ribavirin, achieved limited success, and widespread use of these therapies has been hampered by prevalent side effects. For more than a decade, the HCV RNA-dependent RNA polymerase (RdRp) has been targeted for antiviral development. Direct acting antivirals (DAA) have been identified which bind to one of at least six RdRp inhibitor-binding sites, and are now becoming a mainstay of highly effective and well tolerated antiviral treatment for HCV infection. Here we review the different classes of RdRp inhibitors and their mode of action against HCV. Furthermore, the mechanism of antiviral resistance to each class is described, including naturally occurring resistance-associated variants (RAVs) in different viral strains and genotypes. Finally, we review the impact of these RAVs on treatment outcomes with the newly developed regimens. 相似文献
33.
34.
Annals of Surgical Oncology - 相似文献
35.
36.
Andriy
Derkach Steven C. Moore Simina M. Boca Joshua N. Sampson 《Statistics in medicine》2020,39(18):2423-2436
We consider the scenario where there is an exposure, multiple biologically defined sets of biomarkers, and an outcome. We propose a new two-step procedure that tests if any of the sets of biomarkers mediate the exposure/outcome relationship, while maintaining a prespecified familywise error rate. The first step of the proposed procedure is a screening step that removes all groups that are unlikely to be strongly associated with both the exposure and the outcome. The second step adapts recent advances in postselection inference to test if there are true mediators in each of the remaining candidate sets. We use simulation to show that this simple two-step procedure has higher statistical power to detect true mediating sets when compared with existing procedures. We then use our two-step procedure to identify a set of Lysine-related metabolites that potentially mediate the known relationship between increased body mass index and the increased risk of estrogen-receptor positive breast cancer in postmenopausal women. 相似文献
37.
Sirt5 is known to functionally regulate mitochondrial proteins by altering posttranslational modifications, including lysine desuccinylation. While roles for Sirt5 as either a tumor promoter or suppressor, or in chemoresistance, have been implicated in other cancers, the function of Sirt5 in cutaneous melanoma has not been well examined. Therefore, to determine whether Sirt5 is necessary for BrafV600E‐mediated melanoma formation and/or disease progression, we crossed a genetically engineered murine melanoma model (TyrCreERT2/+; BrafLSL‐V600E/+; Ptenflox/flox) to Sirt5?/? knockout animals. In addition, we tested for synergism with a selective BRAF (V600E) inhibitor in Sirt5?/? mouse melanoma cells. Taken together, this report demonstrates that, in these models, Sirt5 is dispensable for BrafV600E‐mediated cutaneous melanoma formation and growth in vivo, and does not improve sensitivity to a selective BRAF inhibitor. 相似文献
38.
Greaney Mary L. Cohen Steven A. Blissmer Bryan J. Earp Jacob E. Xu Furong 《Quality of life research》2019,28(12):3249-3257
Quality of Life Research - Health-related quality of life (HRQoL) is an important indicator of population health, yet no age-specific trend analyses in HRQoL have been conducted with a nationally... 相似文献
39.
40.